I like that the gloves are off and they are naming and shaming ruxolitinib.
Ann: Remestemcel-L Improves Survival in High-Risk Acute GvHD, page-6
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.000(0.00%) |
Mkt cap ! $1.147B | |||
| Open | High | Low | Value | Volume |
| $1.02 | $1.02 | $1.00 | $820.7K | 814.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 34007 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 46053 | 10 |
View Market Depth
| Last trade - 11.52am 19/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |